FDA Inspection 1310550 — Michael D. Banov, MD
The FDA completed an inspection of Michael D. Banov, MD on March 23, 2026 in Marietta, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 23, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Marietta, GA (United States)
Additional Details
Clinical Investigator (CI)